As of 2024-12-14, the Intrinsic Value of CVS Health Corp (CVS) is
125.83 USD. This CVS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 49.37 USD, the upside of CVS Health Corp is
154.90%.
The range of the Intrinsic Value is 83.61 - 212.51 USD
125.83 USD
Intrinsic Value
CVS Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
83.61 - 212.51 |
125.83 |
154.9% |
| DCF (Growth 10y) |
109.37 - 260.73 |
159.11 |
222.3% |
| DCF (EBITDA 5y) |
81.06 - 133.24 |
102.88 |
108.4% |
| DCF (EBITDA 10y) |
106.50 - 179.70 |
136.81 |
177.1% |
| Fair Value |
99.65 - 99.65 |
99.65 |
101.84% |
| P/E |
80.20 - 134.71 |
104.31 |
111.3% |
| EV/EBITDA |
26.84 - 118.20 |
68.83 |
39.4% |
| EPV |
311.60 - 541.07 |
426.33 |
763.5% |
| DDM - Stable |
25.10 - 60.26 |
42.68 |
-13.5% |
| DDM - Multi |
59.08 - 108.12 |
76.18 |
54.3% |
CVS Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
62,127.70 |
| Beta |
0.19 |
| Outstanding shares (mil) |
1,258.41 |
| Enterprise Value (mil) |
120,786.70 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.03% |
| Cost of Debt |
5.50% |
| WACC |
6.57% |